Virtual Challenging Case Clinic: Multiple Myeloma
- Engage with leading experts to strategize on therapeutic options for your patients
- Stay up to date on novel agents approved for the treatment of multiple myeloma, and assess recommended sequencing of therapy

Course Director
Sagar Lonial, MD, FACP
Chief Medical Officer
Professor and Chair, Department of Hematology and Medical Oncology
Anne and Bernard Gray Family Chair in Cancer
Winship Cancer Institute of Emory University
Atlanta, Georgia
Agenda
- Welcome, Introductions, and Pre-session Survey
- General Disease State and Treatment Guidelines
- Expert Insights: Faculty-submitted cases
- Case Presentation, Polling Questions, and Discussion
- Q&A
- Conclusion and Post-session Survey
Updates from ASH
Sagar Lonial, MD, FACP
Winship Cancer Institute of Emory University | Atlanta, Georgia
Wednesday, January 20, 2021
Emerging Therapeutic Options: What’s On the Horizon?
Adam Cohen, MD
University of Pennsylvania | Philadelphia, Pennsylvania
Broadcast on November 18, 2020
Treating Relapsed/Refractory MM: Sequencing of Therapies
Paul G. Richardson, MD
Dana-Farber Cancer Institute | Boston, Massachusetts
Broadcast on September 16, 2020
Updates from ASCO and EHA
Krina Patel, MD, MSc
The University of Texas MD Anderson Cancer Center | Houston, Texas
Broadcast on July 15, 2020
Maintenance Therapy Approaches
Nina Shah, MD
University of California, San Francisco | San Francisco, California
Broadcast on May 20, 2020
Newly Diagnosed MM Treatment Options
Peter Voorhees, MD
Levine Cancer Institute | Charlotte, North Carolina
Broadcast on March 18, 2020
Target Audience
Learning Objectives
- Evaluate best available evidence regarding the treatment of patients with multiple myeloma
- Assess the implications of emerging clinical trial data regarding multiple myeloma treatment approaches
- Develop strategies to address complicated multiple myeloma cases
Continuing Education
The University of Nebraska Medical Center, Center for Continuing Education designates this activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Nebraska Medical Center, Center for Continuing Education and Bio Ascend.
Disclosure Statement
This activity may include presentations in which presenters may discuss off-label and/or investigational use of pharmaceuticals or instruments not yet FDA-approved. Participants should note that the use of products outside currently FDA-approved labeling should be considered experimental and are advised to consult current prescribing information for FDA-approved indications. All materials are included with the permission of the authors. The opinions expressed are those of the authors and are not to be construed as those of the University of Nebraska Medical Center, Center for Continuing Education or Bio Ascend. The information presented in this activity is not meant to serve as a guideline for patient management; primary references, relevant practice guidelines, and full prescribing information should be consulted.
Contact Us
Questions? Please contact Bio Ascend by phone: 888-476-9129 or email: info@bioascend.com!